- Workers Compensation
- Tractor Trailer Accidents
- Auto Accidents
- Motorcycle Accidents
- Birth Injuries
- Products Liability
- Dangerous Drugs
- Premises Liability/ Slip & Fall
- Social Security Disability
- Wills, Estates & Elder Law
- Links
Dangerous Drug Attorneys - Bextra
Serving all of Pennsylvania
On April 7, 2005, the U.S. Food and Drug Administration asked Pfizer to remove Bextra (Valdecoxib), its popular arthritis pain relief drug, from the market because of serious health risks associated with taking the drug. Concerns include an increased risk of heart attack, stroke, and Stevens Johnson Syndrome, a potentially life threatening skin condition. Bextra belongs to the same class of Cox-2 inhibitor drugs as Vioxx, which Merck & Company had voluntarily withdrawn from the market on September 30, 2004, due to similar safety concerns, and Celebrex, another controversial arthritis drug also manufactured by Pfizer.
The medical community has long expressed concerns about Cox-2 inhibitor drugs, including Bextra, because of the potentially severe side effects. A 2004 study has found that patients who took Bextra were more than twice as likely to suffer heart attack or stroke than those given a placebo. Yet, since Bextra's introduction to the market in 2001 Pfizer has maintained that Bextra is a safe drug putting thousands of people at a higher risk or heart attack, strokes, or serious side effects.
Michael J. O'Connor & Associates represents victims of Bextra side effects and their families throughout Pennsylvania.
FDA U.S. Food and Drug Administration - Center for Drug Evaluation and Research
Additional information about Bextra
The dangerous drug attorneys at Michael J. O'Connor & Associates is ready to begin tackling your legal problem today. Email or call our toll free number at 1.800.518.4LAW for a free initial consultation and review of your case.
